Fatty Acid Binding Protein 3
"Fatty Acid Binding Protein 3" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A small cytosolic fatty-acid binding protein that forms a lipid-binding beta-barrel structure and is expressed by CARDIOMYOCYTES and at lower levels in brain tissue. It is released into plasma immediately following cardiac injury and may therefore serve as a useful biomarker for the early detection of MYOCARDIAL INFARCTION.
Descriptor ID |
D000074026
|
MeSH Number(s) |
D12.776.157.170.125
|
Concept/Terms |
Fatty Acid Binding Protein 3- Fatty Acid Binding Protein 3
- Heart-Specific Fatty Acid Binding Protein
- Heart Specific Fatty Acid Binding Protein
- Muscle Fatty Acid-Binding Protein
- Muscle Fatty Acid Binding Protein
- Heart Fatty Acid Binding Protein
- H-FABP
|
Below are MeSH descriptors whose meaning is more general than "Fatty Acid Binding Protein 3".
Below are MeSH descriptors whose meaning is more specific than "Fatty Acid Binding Protein 3".
This graph shows the total number of publications written about "Fatty Acid Binding Protein 3" by people in this website by year, and whether "Fatty Acid Binding Protein 3" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2009 | 0 | 1 | 1 |
2012 | 0 | 1 | 1 |
2016 | 1 | 0 | 1 |
2017 | 1 | 1 | 2 |
2018 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Fatty Acid Binding Protein 3" by people in Profiles.
-
Correlation between Heart fatty acid binding protein and severe COVID-19: A case-control study. PLoS One. 2020; 15(4):e0231687.
-
Risk stratification of acute pulmonary embolism based on clinical parameters, H-FABP and multidetector CT. Int J Cardiol. 2018 Aug 15; 265:223-228.
-
Differential role of CSF fatty acid binding protein 3, a-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementia. Alzheimers Res Ther. 2017 Jul 28; 9(1):52.
-
Are Markers of Cardiac Dysfunction Useful in the Assessment of Cardiovascular Risk in Dialysis Patients? Curr Pharm Des. 2017; 23(20):3024-3033.
-
Heart-type fatty acid-binding protein after ultramarathon running and relationship with high-sensitivity troponin I. J Cardiovasc Med (Hagerstown). 2016 12; 17 Suppl 2:e252-e253.
-
A simple score for rapid risk assessment of non-high-risk pulmonary embolism. Clin Res Cardiol. 2013 Jan; 102(1):73-80.
-
Cardiac involvement in dengue virus infections during the 2004/2005 dengue fever season in Sri Lanka. Southeast Asian J Trop Med Public Health. 2009 Jul; 40(4):727-30.